secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2024-08-19T23:59:59+00:00
Accession:  0001104659-24-090867
Event type: debt
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics prices $1.85B in senior notes to fund LifeLabs acquisition
----------------------------------------------------------------------------

- Issued $400M at 4.600% due 2027, $600M at 4.625% due 2029, $850M at 5.000% due 2034.
- Net proceeds to fund LifeLabs purchase price and related costs, plus general corporate purposes.
- 2027 and 2029 notes subject to special mandatory redemption at 101% if LifeLabs deal not completed.
- 2034 notes will remain outstanding even if LifeLabs acquisition is not consummated.
- By-laws amended to provide officer exculpation as permitted by Delaware law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/0001104659-24-090867-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000110465924090867/tm2421254d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-090867

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer